Unknown

Dataset Information

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.


ABSTRACT:

Background

With the onset of prevention trials for individuals at high risk for Alzheimer disease, there is increasing need for accurate risk prediction to inform study design and enrollment, but available risk estimates are limited. We developed risk estimates for the incidence of mild cognitive impairment (MCI) or dementia among cognitively unimpaired individuals by APOE-e4 dose for the genetic disclosure process of the Alzheimer's Prevention Initiative Generation Study, a prevention trial in cognitively unimpaired APOE-e4/e4 homozygote individuals.

Methods and findings

We included cognitively unimpaired individuals aged 60-75 y, consistent with Generation Study eligibility criteria, from the National Alzheimer's Coordinating Center (NACC) (n = 5,073, 158 APOE-e4/e4), the

SUBMITTER: Qian J 

PROVIDER: S-EPMC5360223 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature